ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,255.20
      1.29%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.54
      0.03%
      Bitcoin
      67,565.58
      -0.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. InflaRx NV (IFRX) Quote

      InflaRx NV

      InflaRx NV (IFRX)

      NASDAQ
      1.53
      0.01
      (0.66%)
      At close: July 22 4:00PM
      Delayed by 15 minutes
      1.53
      0.00
      ( 0.00% )
      After Hours: 7:47PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.53
      Bid
      1.62
      Ask
      1.65
      Volume
      32,238
      1.5175 Day's Range 1.5925
      1.14 52 Week Range 4.30
      Market Cap
      89.503M
      Previous Close
      1.52
      Open
      1.54
      Last Trade
      202
      @
      1.53
      Last Trade Time
      Financial Volume
      $ 49,938
      VWAP
      1.549
      Average Volume (3m)
      151,211
      Shares Outstanding
      58,883,272
      Dividend Yield
      -
      PE Ratio
      -2.14
      Earnings Per Share (EPS)
      -0.72
      Revenue
      63k
      Net Profit
      -42.67M

      About InflaRx NV

      InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator in... InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.inflarx.de
      Headquarters
      Jena, Deu
      Founded
      1970
      InflaRx NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IFRX. The last closing price for InflaRx NV was $1.52. Over the last year, InflaRx NV shares have traded in a share price range of $ 1.14 to $ 4.30.

      InflaRx NV currently has 58,883,272 shares outstanding. The market capitalization of InflaRx NV is $89.50 million. InflaRx NV has a price to earnings ratio (PE ratio) of -2.14.

      IFRX Latest News

      More News

      InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)

      JENA, Germany, June 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced...

      June 24 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      June 05 2024
      Edgar (US Regulatory)

      InflaRx Hosts R&D Event Highlighting the Promise of INF904

      Thought leaders in complement inhibition, chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) provide compelling new insights into the strong development rationales, potential...

      June 05 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 21 2024
      Edgar (US Regulatory)

      InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

      JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced...

      May 21 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 08 2024
      Edgar (US Regulatory)

      InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update

      Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the opportunity, the role of C5aR in chronic spontaneous urticaria (CSU) and...

      May 08 2024
      GlobeNewswire Inc.

      InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024

      JENA, Germany, April 30, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

      April 30 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.06-3.773584905661.591.721.51778381.62296474CS
      4-0.05-3.164556962031.581.77091.5845811.64391588CS
      120.1611.67883211681.371.841.1651512111.48967323CS
      26-0.07-4.3751.61.921.1651887711.53787672CS
      52-2.64-63.3093525184.174.31.142439251.87272935CS
      156-1.1-41.8250950572.637.24990.77626617493.89986682CS
      260-1.34-46.68989547042.879.70.77626302964.18774258CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MIRAMIRA Pharmaceuticals Inc
      $ 5.01
      (627.35%)
      		157.94M
      CMAXCareMax Inc
      $ 5.19
      (228.48%)
      		102.61M
      NUKKNukkleus Inc
      $ 0.499
      (55.94%)
      		26.19M
      SNOASonoma Pharmaceuticals Inc
      $ 0.423
      (37.34%)
      		4.87M
      ONDSOndas Holdings Inc
      $ 1.1297
      (34.06%)
      		2.19M
      LGCBLinkage Global Inc
      $ 3.6601
      (-29.82%)
      		168k
      CGBSCrown LNG Holdings Ltd
      $ 0.9997
      (-29.10%)
      		3.38M
      SPECSpectaire Holdings Inc
      $ 0.3962
      (-24.53%)
      		1.87M
      GSUNGolden Sun Health Technology Group Ltd
      $ 5.13
      (-23.66%)
      		158.58k
      PSNLPersonalis Inc
      $ 2.9808
      (-22.58%)
      		3.1M
      NVDANVIDIA Corporation
      $ 123.54
      (4.76%)
      		238.8M
      SQQQProShares UltraPro Short QQQ
      $ 8.09
      (-4.37%)
      		183.24M
      MIRAMIRA Pharmaceuticals Inc
      $ 5.01
      (627.35%)
      		157.94M
      SERVServe Robotics Inc
      $ 8.73
      (15.63%)
      		151.44M
      NCPLNetcapital Inc
      $ 0.1118
      (7.50%)
      		124.21M

      IFRX Discussion

      View Posts
      Monksdream Monksdream 2 days ago
      IFRX under $2
      👍️0
      Monksdream Monksdream 2 weeks ago
      IFRX under $2
      👍️0
      glenn1919 glenn1919 1 month ago
      IFRX..................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      ralfito ralfito 2 months ago
      What is up with IFRX? Seems to be teetering. Numbers look good, except for Forward EPS.
      👍️0
      glenn1919 glenn1919 2 months ago
      IFRX...............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 3 months ago
      IFRX under $2
      👍️0
      Monksdream Monksdream 4 months ago
      IFRX under $2
      👍️0
      glenn1919 glenn1919 4 months ago
      IFRX................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 5 months ago
      IFRX under $2
      👍️0
      Monksdream Monksdream 8 months ago
      IFRX new 52 week low
      👍️0
      TheFinalCD TheFinalCD 9 months ago
      https://finviz.com/quote.ashx?t=IFRX&ty=c&ta=1&p=d

      does have a REGISTERED SHELF OFFERING

      https://dilutiontracker.com/app/search/IFRX?a=dbb88c

      Apr-05-23 Upgrade Guggenheim Neutral ? Buy $8
      👍️0
      enthalpy enthalpy 1 year ago
      True waiting on that skin cancer p2 data release or EUA sales update.
      👍️0
      peterus peterus 1 year ago
      going the wronge way
      👍️0
      peterus peterus 1 year ago
      yup $10+ coming
      👍️0
      enthalpy enthalpy 1 year ago
      I added more and its a decent position. I think we have a shot at 10 to 15 short term. Friday looked promising. Hopefully we get a second wave to start in 2 weeks.
      👍️0
      peterus peterus 1 year ago
      you still in ????
      im still holding 4s
      👍️0
      Gator44 Gator44 1 year ago
      Closing of offering, here comes first stop $6.25
      👍️0
      frans frans 1 year ago
      IFRX should go slowly 5$ +
      👍️0
      frans frans 1 year ago
      IFRX 4.2 now slowly on the move
      👍️0
      frans frans 1 year ago
      in here at 4.10
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Still in downtrend and they will keep diluting
      👍️0
      enthalpy enthalpy 1 year ago
      I bought more 4.04
      👍️0
      Gator44 Gator44 1 year ago
      Couple of pennies are cloce enough
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Learn your charts lol $3.93 is the gap fill
      👍️0
      Gator44 Gator44 1 year ago
      Gap filled boys and girls...
      Big boy buying today !!!
      👍️0
      peterus peterus 1 year ago
      dont think we will see 3.50s
      but it could happen with this market
      👍️0
      enthalpy enthalpy 1 year ago
      Whats your thoughts on it hitting 3.50?
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      When it hits $3.93 tomorrow is where I’ll be buying my first order
      👍️0
      enthalpy enthalpy 1 year ago
      Tomorrow we probably hit 3.75ish and that's close enough to the 62% fibonacci pullback. If it hits 3.75 rsi will be around mid 50s give or take which is good.
      👍️0
      enthalpy enthalpy 1 year ago
      Probably right. I loaded some at 4.20 with rsi at 61 but i think 3.75 is the target. Glta.
      👍️0
      peterus peterus 1 year ago
      beter on side line and buy bottom
      👍️0
      peterus peterus 1 year ago
      it wil but not today
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      I thought you said going to $10 lol now you’re on the sideline this going to test the gaps fill $3.93
      👍️0
      peterus peterus 1 year ago
      im still on side line
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      I disagree I’m going to be buying at $3.93 that’s the gap fill
      👍️0
      peterus peterus 1 year ago
      4.40s 4.50s could be stronge support
      👍️0
      peterus peterus 1 year ago
      agree
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Ok today we will see $4 first step
      👍️0
      peterus peterus 1 year ago
      lol will never see $2 maybe in your dreams lol
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Lol ?? you’re delusional major diluting down to $2
      👍️0
      enthalpy enthalpy 1 year ago
      I will be loading on the 10 million share offering. Looking for $3.50ish.
      👍️0
      RobP33 RobP33 1 year ago
      New highs by EOW???
      👍️0
      enthalpy enthalpy 1 year ago
      Only had 2 minutes missed the 4.60 buy.
      👍️0
      enthalpy enthalpy 1 year ago
      We will see i have 1/3 of position bet at $5.00 but im playing this by the book.
      👍️0
      peterus peterus 1 year ago
      yup i think you could be right
      👍️0
      enthalpy enthalpy 1 year ago
      Fibonacci 38% pull back is $5.00 and 62% pull back is around $4.00. 78% is even further. Either one works. I flipped once for a big win but i think the second wave over several weeks will take this over $12.00.
      👍️0
      peterus peterus 1 year ago
      fliped out
      side line ... waiting
      👍️0
      enthalpy enthalpy 1 year ago
      Waiting for $4.00. Enjoy the ride down.
      👍️0
      enthalpy enthalpy 1 year ago
      Picked up 1/4 at 5.00. Waiting for rest around low 4.00ish.
      👍️0
      the_stockoracle the_stockoracle 1 year ago
      Guys man why didn’t you take your profits when it jumped up huge mm’s are going to bring this back down to probably $3 to make back their money ?? if this was a pandemic full blown this would of hit $15 range but it isn’t revenues are way too small especially with all those others Covid therapies
      👍️0

      Your Recent History

      NASDAQ
      IFRX
      InflaRx NV
      Delayed Upgrade Clock